共 50 条
- [1] Efficacy and Safety of 5-Fluorouracil 0.5%/Salicylic Acid 10% in the Field-Directed Treatment of Actinic Keratosis: A Phase III, Randomized, Double-Blind, Vehicle-Controlled TrialDERMATOLOGY AND THERAPY, 2017, 7 (01) : 81 - 96Stockfleth, Eggertvon Kiedrowski, RalphDominicus, RolfRyan, JohnEllery, AdamFalques, MeritxellIvanoff, NathalieRodriguez Azeredo, Rosario
- [2] Erratum to: Efficacy and Safety of 5-Fluorouracil 0.5%/Salicylic Acid 10% in the Field-Directed Treatment of Actinic Keratosis: A Phase III, Randomized, Double-Blind, Vehicle-Controlled TrialDermatology and Therapy, 2017, 7 : 263 - 263Eggert StockflethRalph von KiedrowskiRolf DominicusJohn RyanAdam ElleryMeritxell FalquésNathalie IvanoffRosario Rodriguez Azeredo
- [3] Efficacy and Safety of 5-Fluorouracil 0.5%/Salicylic Acid 10% in the Field-Directed Treatment of Actinic Keratosis: A Phase III, Randomized, Double-Blind, Vehicle-Controlled Trial (vol 7, pg 81, 2017)DERMATOLOGY AND THERAPY, 2017, 7 (02) : 263 - 263Stockfleth, Eggertvon Kiedrowski, RalphDominicus, RolfRyan, JohnEllery, AdamFalques, MeritxellIvanoff, NathalieRodriguez Azeredo, Rosario
- [4] Evaluation of 5-fluorouracil 0.5%/salicylic acid 10% in the field-directed treatment of actinic keratosis: a Phase III, randomised, vehicle-controlled trialMELANOMA RESEARCH, 2016, 26 : E10 - E10Stockfleth, E.von Kiedrowski, R.Dominicus, R.Ryan, J.Ellery, A.Falques, M.Ivanoff, N.Rodriguez Azeredo, R.
- [5] Predictors of response to 5-fluorouracil 0.5%/salicylic acid 10% in the field-directed treatment of actinic keratosis: A post hoc analysis of a phase III, randomized, vehicle-controlled trialJOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2017, 76 (06) : AB202 - AB202Stockfleth, EggertRyan, JohnFalques, MeritxellIvanoff, NathalieRodriguez Azeredo, RosarioVilardell, David
- [6] Use of reflectance confocal microscopy to evaluate 5-fluorouracil 0.5%/salicylic acid 10% in the field-directed treatment of subclinical lesions of actinic keratosis: subanalysis of a Phase III, randomized, double-blind, vehicle-controlled trialJOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2018, 32 (03) : 390 - 396Ulrich, M.Reinhold, U.Falques, M.Rodriguez Azeredo, R.Stockfleth, E.
- [7] In vivo Reflectance Confocal Microscopy Characterization of Field-Directed 5-Fluorouracil 0.5%/Salicylic Acid 10% in Actinic KeratosisDERMATOLOGY, 2015, 230 (03) : 193 - 198Ulrich, MartinaAlarcon, IvetteMalvehy, JosepPuig, Susana
- [8] Imiquimod 5% cream for the treatment of actinic keratosis: Results from a phase III, randomized, double-blind, vehicle-controlled, clinical trial with histologyJOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2004, 51 (04) : 547 - 555Szeimies, RMGerritsen, MJRGupta, GOrtonne, JPSerresi, SBichel, JLee, JHFox, TLAlomar, A
- [9] Randomized, vehicle-controlled trials of topical 5-fluorouracil therapy for actinic keratosis treatment: an overviewIMMUNOTHERAPY, 2012, 4 (09) : 939 - 945Rhavar, MaralLamel, Sonia A.Maibach, Howard I.
- [10] Efficacy and safety of topical SR-T100 gel in treating actinic keratosis in Taiwan: A Phase III randomized double-blind vehicle-controlled parallel trialJOURNAL OF DERMATOLOGICAL SCIENCE, 2018, 90 (03) : 295 - 302Yang, Chao-ChunWong, Tak-WahLee, Chih-HungHong, Chien-HuiChang, Chung-HsingLai, Feng-JieLin, Shang-HungChi, Ching-ChiLin, Tzu-KaiYen, HsiWu, Chin-HanSheu, Hamm-MingLan, Cheng-Che E.